Editor’s Note: This article is part of Joanna Makris’ Behind the Wall series, where she provides retail investors with the insider scoop on the hottest technologies and trends from today’s business leaders, industry experts and money managers. Today’s discussion is with Dustin Robinson, founder of venture capital firm Iter Investments, an early investor and policymaker in…

Compass Pathways (NASDAQ:CMPS) has been beaten up lately. But the fundamentals are rapidly improving, making now a great time to buy this psychedelic stock. Source: Shutterstock CMPS and other companies championing psychedelic-based therapies are seeing legalization tailwinds grow rapidly. Many cities across the U.S. are in talks to decriminalize psilocybin, among other substances. Cities in…

Source: local_doctor / Shutterstock.com It wasn’t long before marijuana was considered a taboo. Emerging science, however, has altered customer perceptions and has paved a path for its legalization. As a result, the global legal marijuana market continues to expand at an impressive rate. Most recently, PSY (NYSEARCA:PSY), the first psychedelic stock ETF, hit the market.…